10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2022 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 15, 2023) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Operating activities | |||
| Net Income | $ 6,019 | 6,095 | 4,572 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net losses (gains) on financial instruments | 550 | (318) | (182) |
| Equity in net earnings of other invested assets | (293) | (562) | (51) |
| Depreciation and amortization | 1,675 | 1,302 | 1,154 |
| Deferred income taxes | (76) | 326 | (540) |
| Impairment of property and equipment | 7 | 73 | 198 |
| Share-based compensation | 264 | 255 | 283 |
| Changes in operating assets and liabilities: | |||
| Receivables, net | (2,510) | (2,138) | (256) |
| Other invested assets | 11 | (70) | (32) |
| Other assets | 120 | 37 | (283) |
| Policy liabilities | 2,254 | 2,597 | 3,528 |
| Unearned income | (42) | (113) | 202 |
| Accounts payable and other liabilities | 824 | 719 | 1,978 |
| Income taxes | (338) | 140 | 72 |
| Other, net | (66) | 21 | 45 |
| Net cash provided by operating activities | 8,399 | 8,364 | 10,688 |
| Investing activities | |||
| Purchases of investments | (24,946) | (18,669) | (19,492) |
| Proceeds from sale of investments | 11,988 | 10,269 | 11,318 |
| Maturities, calls and redemptions from investments | 10,620 | 4,344 | 4,741 |
| Changes in securities lending collateral | (301) | (956) | (849) |
| Purchases of subsidiaries, net of cash acquired | (649) | (3,476) | (1,976) |
| Purchases of property and equipment | (1,152) | (1,087) | (1,021) |
| Other, net | (120) | (63) | (45) |
| Net cash used in investing activities | (4,560) | (9,638) | (7,324) |
| Financing activities | |||
| Net (repayments of) proceeds from commercial paper borrowings | (300) | 50 | (150) |
| Proceeds from long-term borrowings | 3,071 | 3,462 | 2,484 |
| Repayments of long-term borrowings | (1,899) | (1,068) | (1,932) |
| Proceeds from short-term borrowings | 1,365 | 1,325 | 970 |
| Repayments of short-term borrowings | (1,375) | (1,050) | (1,670) |
| Changes in securities lending payable | 302 | 956 | 849 |
| Changes in bank overdrafts | 933 | (376) | 486 |
| Repurchase and retirement of common stock | (2,316) | (1,900) | (2,700) |
| Cash dividends | (1,229) | (1,104) | (954) |
| Proceeds from issuance of common stock under employee stock plans | 182 | 203 | 176 |
| Taxes paid through withholding of common stock under employee stock plans | (93) | (102) | (128) |
| Other, net | 41 | 27 | 2 |
| Net cash (used in) provided by financing activities | (1,318) | 423 | (2,567) |
| Effect of foreign exchange rates on cash and cash equivalents | (14) | (10) | 7 |
| Change in cash and cash equivalents | 2,507 | (861) | 804 |
| Cash and cash equivalents at beginning of year | 4,880 | 5,741 | |
| Cash and cash equivalents at end of year | 7,387 | 4,880 | 5,741 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |